Acceptance and commitment therapy on cancer patients
Not Applicable
Recruiting
- Conditions
- Breast cancer.Malignant neoplasm of breast
- Registration Number
- IRCT2017100615590N5
- Lead Sponsor
- Vice chancellor for research,Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Diagnosis of breast cancer; Self awareness from cancer; high education in patients Exclusion criteria: Have other disease (for example: other kind of cancer); Lack of knowledge regarding the disease; lack of inclination of patients for attending at intervention sessions
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cognitive emotion regulation. Timepoint: Before treatment and 1 week after. Method of measurement: Cognitive emotion regulation Questionnaire.;Pain related anxiety. Timepoint: Before treatment and 1 week after. Method of measurement: Pain related anxiety Questionnaire.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie ACT's impact on pain-related anxiety in breast cancer patients?
How does group ACT compare to standard psychological interventions for cognitive emotion regulation in breast cancer?
Are there specific biomarkers associated with improved outcomes in ACT-treated breast cancer patients?
What adverse events are commonly reported with ACT in oncology settings and how are they managed?
What combination therapies show synergistic effects with ACT in managing breast cancer-related anxiety?